Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 2: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 3: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
Conditions
Interventions
Intervention1: Group I: Patients will receive single dose of Rocuronium 0.06 mg/kg diluted to 2ml intravenously: Group II: Patients will receive single dose of normal saline of 2ml intravenously
Inte
Sponsors
Department of Anaesthesia
Eligibility
Inclusion criteria
Inclusion criteria: Patient scheduled under general anaesthesia for elective surgery, MPG I and II, Asa I and II
Exclusion criteria
Exclusion criteria: 1 Patients with comorbidity 2 ASA III and IV 3 MPG III and IV (difficult airway) 4 Age 60 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the pretreatment with rocuronium in preventing fasciculation caused by succinylcholine in patient posted for surgery under general anaesthesia.Timepoint: Intra operative period | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of rocuronium pre-treatment in preventing postoperative myalgia in post anesthesia care unit and myalgia at 24 hours in patients undergoing elective surgery.Timepoint: Post operative period | — |
Countries
India
Contacts
Public ContactSapna Bansal
MM Institute of Medical Sciences
Outcome results
None listed